Company Filing History:
Years Active: 2023
Title: Sergey Tesier: Innovator in Pharmaceutical Development
Introduction
Sergey Tesier is a notable inventor based in Monroe, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of highly purified batches of pharmaceutical-grade migalastat.
Latest Patents
Sergey Tesier holds 1 patent for his work titled "Highly purified batches of pharmaceutical grade migalastat and methods of producing the same." This patent provides methods for producing a batch of 1,2,3,6-tetrapivaloyl-D-galactofuranoside and 5-azido-5-deoxy-1,2,3,6-tetrapivaloyl-D-galactofuranoside. It also includes methods for determining the purity of these compounds and assessing the suitability of migalastat hydrochloride for medical use.
Career Highlights
Sergey Tesier is currently employed at Amicus Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving the production and distribution methods of critical pharmaceutical compounds.
Collaborations
Throughout his career, Sergey has collaborated with notable colleagues, including Kamlesh A Sheth and James Cartwright. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Sergey Tesier's contributions to pharmaceutical innovation highlight the importance of research and development in improving medical treatments. His work continues to impact the industry positively.